Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia

Journal of Molecular Medicine

Volumn 85, Issue 2, 2007, Pages 149-161

  Hims, Matthew M ^a   Ibrahim, El Chérif ^b,d   Leyne, Maire ^a   Mull, James ^a   Liu, Lijuan ^a   Lazaro, Conxi ^a,c   Shetty, Ranjit S ^a   Gill, Sandra ^a   Gusella, James F ^a   Reed, Robin ^b   Slaugenhaupt, Susan A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d Mediterranée University   (France)

Author keywords

Dysautonomia; Kinetin; mRNA splicing

Indexed keywords

I KAPPA B KINASE; KINETIN;

ARTICLE; CONTROLLED STUDY; DYSAUTONOMIA; EXON; FAMILIAL DISEASE; GENE; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; HUMAN CELL; IKBKAP GENE; LYMPHOBLAST; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; RNA SPLICING;

CARRIER PROTEINS; CELL LINE, TUMOR; DYSAUTONOMIA, FAMILIAL; EXONS; HUMANS; KINETIN; NEUROFIBROMATOSES; RNA SPLICING; RNA, MESSENGER;

EID: 33846574156     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0137-2     Document Type: Article

References (50)

1. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-2144
2. Sorek R, Shamir R, Ast G (2004) How prevalent is functional alternative splicing in the human genome? Trends Genet 20:68-71
3. Modrek B, Resch A, Grasso C, Lee C (2001) Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res 29:2850-2859
4. Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17:419-437
5. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285-298
6. Svenson IK, Ashley-Koch AE, Gaskell PC, Riney TJ, Cumming WJ, Kingston HM, Hogan EL, Boustany RM, Vance JM, Nance MA et al (2001) Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet 68:1077-1085
7. Beck S, Penque D, Garcia S, Gomes A, Farinha C, Mata L, Gulbenkian S, Gil-Ferreira K, Duarte A, Pacheco P et al (1999) Cystic fibrosis patients with the 3272-26A->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane. Hum Mutat 14:133-144
8. Nissim-Rafinia M, Kerem B (2005) The splicing machinery is a genetic modifier of disease severity. Trends Genet 21:480-483
9. Moller LB, Tumer Z, Lund C, Petersen C, Cole T, Hanusch R, Seidel J, Jensen LR, Horn N (2000) Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. Am J Hum Genet 66:1211-1220
10. Garcia-Blanco MA (2003) Mending the message. Nat Biotechnol 21:1448-1449
11. Garcia-Blanco MA, Baraniak AP, Lasda EL (2004) Alternative splicing in disease and therapy. Nat Biotechnol 22:535-546
12. Yeo GW (2005) Splicing regulators: targets and drugs. Genome Biol 6:240
13. Pearson J (1979) Familial dysautonomia (a brief review). J Auton Nerv Syst 1:119-126
14. Axelrod FB (1995) Familial Dysautonomia. Harwood Academic, Luxembourg
15. Lehavi O, Aizenstein O, Bercovich D, Pavzner D, Shomrat R, Orr-Urtreger A, Yaron Y (2003) Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews. Genet Test 7:139-142
16. Maayan C, Kaplan E, Shachar S, Peleg O, Godfrey S (1987) Incidence of familial dysautonomia in Israel 1977-1981. Clin Genet 32:106-108
17. Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi SA, Ekstein J, Rubin BY (2001) Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 68:753-758
18. Leyne M, Mull J, Gill SP, Cuajungco MP, Oddoux C, Blumenfeld A, Maayan C, Gusella JF, Axelrod FB, Slaugenhaupt SA (2003) Identification of the first non-Jewish mutation in familial dysautonomia. Am J Med Genet A 118:305-308
19. Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L et al (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598-605
20. Cuajungco MP, Leyne M, Mull J, Gill SP, Lu W, Zagzag D, Axelrod FB, Maayan C, Gusella JF, Slaugenhaupt SA (2003) Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia. Am J Hum Genet 72:749-758
21. Byers PH (2002) Killing the messenger: new insights into nonsense-mediated mRNA decay. J Clin Invest 109:3-6
22. Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hims MM, Quintero F, Axelrod FB, Gusella JF (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13:429-436
23. Close P, Hawkes N, Cornez I, Creppe C, Lambert CA, Rogister B, Siebenlist U, Merville MP, Slaugenhaupt SA, Bours Vet al (2006) Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell 22:521-531
24. Ibrahim EC, Hims MM, Shomron N, Burge CB, Slaugenhaupt SA, Reed R (2006) Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia. Hum Mutat 2006 Sep 8 [Epub ahead of print]
25. Cohen L, Henzel WJ, Baeuerle PA (1998) IKAP is a scaffold protein of the IkappaB kinase complex. Nature 395:292-296
26. Krappmann D, Hatada EN, Tegethoff S, Li J, Klippel A, Giese K, Baeuerle PA, Scheidereit C (2000) The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J Biol Chem 275:29779-29787
27. Hawkes NA, Otero G, Winkler GS, Marshall N, Dahmus ME, Krappmann D, Scheidereit C, Thomas CL, Schiavo G, Erdjument-Bromage H et al (2002) Purification and characterization of the human elongator complex. J Biol Chem 277:3047-3052
28. Jablonowski D, Zink S, Mehlgarten C, Daum G, Schaffrath R (2006) tRNAGlu wobble uridine methylation by Trm9 identifies Elongator's key role for zymocin-induced cell death in yeast. Mol Microbiol 59:677-688
29. Rahl PB, Chen CZ, Collins RN (2005) Elp1p, the yeast homolog of the FD disease syndrome protein, negatively regulates exocytosis independently of transcriptional elongation. Mol Cell 17:841-853
30. Holmberg C, Katz S, Lerdrup M, Herdegen T, Jaattela M, Aronheim A, Kallunki T (2002) A novel specific role for I-kappa B kinase complex-associated protein in cytosolic stress signaling. J Biol Chem 10:10
31. Heemskerk J, Tobin AJ, Bain LJ (2002) Teaching old drugs new tricks. Meeting of the Neurodegeneration Drug Screening Consortium, 7-8 April 2002, Washington, DC, USA. Trends Neurosci 25:494-496
32. Blumenfeld A, Slaugenhaupt SA, Axelrod FB, Lucente DE, Maayan C, Liebert CB, Ozelius LJ, Trofatter JA, Haines JL, Breakefield XO et al (1993) Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis. Nat Genet 4:160-164
33. Sorek R, Shemesh R, Cohen Y, Basechess O, Ast G, Shamir R (2004) A non-EST-based method for exon-skipping prediction. Genome Res 14:1617-1623
34. Lambert J, Naeyaert JM, Callens T, De Paepe A, Messiaen L (1998) Human myosin V gene produces different transcripts in a cell type-specific manner. Biochem Biophys Res Commun 252:329-333
35. Glatz DC, Rujescu D, Tang Y, Berendt FJ, Hartmann AM, Faltraco F, Rosenberg C, Hulette C, Jellinger K, Hampel H et al (2006) The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J Neurochem 96:635-644
36. Coulter LR, Landree MA, Cooper TA (1997) Identification of a new class of exonic splicing enhancers by in vivo selection. Mol Cell Biol 17:2143-2150
37. Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297:1007-1013
38. Dominski Z, Kole R (1991) Selection of splice sites in premRNAs with short internal exons. Mol Cell Biol 11:6075-6083
39. Xu R, Teng J, Cooper TA (1993) The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol Cell Biol 13:3660-3674
40. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15:541-555
41. Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9:237-247
42. Ars E,KruyerH,MorellM, Pros E, Serra E, Ravella A, EstivillX and Lazaro C (2003) Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 40:e82
43. Rattan SI, Clark BF (1994) Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun 201:665-672
44. Olsen A, Siboska GE, Clark BF, Rattan SI (1999) N(6)-Furfuryladenine, kinetin, protects against Fenton reaction-mediated oxidative damage to DNA. Biochem Biophys Res Commun 265:499-502
45. Verbeke P, Siboska GE, Clark BF, Rattan SI (2000) Kinetin inhibits protein oxidation and glycoxidation in vitro. Biochem Biophys Res Commun 276:1265-1270
46. McCullough JK (2002) Clinical study of safety and efficacy of using topical kinetin 0.1% (Kinerase) to treat photodamaged skin. Cosmet Dermatol 15:29
47. Holste D, Huo G, Tung V, Burge CB (2006) HOLLYWOOD: a comparative relational database of alternative splicing. Nucleic Acids Res 34:D56-D62
48. Soret J, Bakkour N, Maire S, Durand S, Zekri L, Gabut M, Fic W, Divita G, Rivalle C, Dauzonne D et al (2005) Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Proc Natl Acad Sci U S A 102:8764-8769
49. Singh R, Valcarcel J (2005) Building specificity with nonspecific RNA-binding proteins. Nat Struct Mol Biol 12:645-653
50. Carmel I, Tal S, Vig I, Ast G (2004) Comparative analysis detects dependencies among the 5′ splice-site positions. RNA 10:828-840